HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HBW Market News: COVID-19 Donations And Support, Shifts To Sanitizer Production

Executive Summary

Boston coalition offers pro-bono legal help for small businesses, nonprofits; CBD firms Neptune Wellness Solutions and cbdMD respond to loosened US prohibitions for preparing sanitizers; Modere supplements provides first responders with free products; Young Living donates sanitizer in community; VidaFuel Nutition provides protein drinks to vulnerable kidney patients.

You may also be interested in...



US HBW Business News: OTC Migraine Treatment Device Cleared, Nestle Closes Aimmune Deal, More

Cefaly touts first OTC dual-Purpose eTNS migraine device available in US; Nestle Health Science closes on its acquisition of Aimmune Therapeutics; Elderberry supplement marketer Matherson Organics complies with NAD recommendations rather than face FTC scrutiny; and nutrition product firm Vidafuel closes on $1.6m financing round.

Subscription Oral Care Marketer Burst Adjusts Brand Building Program To COVID-19 Shutdowns

The firm says during COVID-19 pandemic, it is waiving the $20 registration fee for its Burst Ambassador program to assist dental hygienists whose offices have closed temporarily, or remain open but put them at risk through close contact with patients and co-workers, potential contamination of saliva and shortage of protective equipment.

Pandemic Could Turn Supplement Firms To Drug Production, Helping Fill Public Health Gaps

The Covid-19 pandemic could push food and supplement manufacturers to switch to manufacturing OTC or Rx drugs to help fill public health gaps, says a former deputy director of FDA's Office of Dietary Supplement Programs. Many marketers are well equipped to make OTC drugs, he added in FDLI webinar.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149907

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel